NICE Ltd.
NICE Ltd. (NCSYF) Financial Performance & Income Statement Overview
Analyze NICE Ltd. (NCSYF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
NICE Ltd. (NCSYF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for NICE Ltd. NCSYF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $700.19M | $721.60M | $689.96M | $664.40M |
| Cost of Revenue | $232.08M | $232.39M | $229.69M | $224.78M |
| Gross Profit | $468.11M | $489.21M | $460.28M | $439.62M |
| Gross Profit Ratio | $0.67 | $0.68 | $0.67 | $0.66 |
| R&D Expenses | $89.10M | $94.75M | $91.50M | $86.52M |
| SG&A Expenses | $230.84M | $240.15M | $227.40M | $224.27M |
| Operating Expenses | $319.94M | $334.90M | $318.90M | $310.79M |
| Total Costs & Expenses | $552.02M | $567.29M | $548.58M | $535.58M |
| Interest Income | $15.85M | $23.05M | $12.28M | $0.00 |
| Interest Expense | $0.00 | $5.27M | $0.00 | $0.00 |
| Depreciation & Amortization | $43.44M | $48.78M | $52.96M | $51.52M |
| EBITDA | $191.61M | $262.12M | $194.34M | $180.34M |
| EBITDA Ratio | $0.27 | $0.36 | $0.28 | $0.27 |
| Operating Income | $148.17M | $154.31M | $141.38M | $128.82M |
| Operating Income Ratio | $0.21 | $0.21 | $0.20 | $0.19 |
| Other Income/Expenses (Net) | $15.85M | $16.94M | $12.28M | $15.64M |
| Income Before Tax | $164.02M | $171.25M | $153.66M | $144.47M |
| Income Before Tax Ratio | $0.23 | $0.24 | $0.22 | $0.22 |
| Income Tax Expense | $34.73M | $71.74M | $32.74M | $28.68M |
| Net Income | $129.29M | $99.51M | $120.92M | $115.78M |
| Net Income Ratio | $0.18 | $0.14 | $0.18 | $0.17 |
| EPS | $2.04 | $1.51 | $1.87 | $1.76 |
| Diluted EPS | $2.01 | $1.51 | $1.84 | $1.76 |
| Weighted Avg Shares Outstanding | $63.35M | $65.79M | $64.63M | $65.79M |
| Weighted Avg Shares Outstanding (Diluted) | $64.37M | $65.86M | $65.86M | $65.86M |
Financial performance has remained strong, with revenue growing from $664.40M in Q2 2024 to $700.19M in Q1 2025. Gross profit continued to perform well, with margins at 67% in the latest quarter. Operating income reached $148.17M in Q1 2025, holding a steady 21% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $191.61M. Net income rose to $129.29M, keeping EPS at $2.04. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan